Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
Q4 2021 vs. Q3 2021
How the institutions holding Mesoblast Ltd changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 41 | 42 | +1 |
| Shares | 3.53M | 3.32M | −208.1K (−5.9%) |
| Value | $21.2M | $16.2M | −$5.01M (−23.6%) |
New holders (9)
Institutions that held Mesoblast Ltd at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 44,679 | $214.0K | 0.02% |
| Lattice Capital Management, LLC | 30,100 | $144.0K | 0.15% |
| Sio Capital Management, LLC | 26,660 | $128.0K | 0.04% |
| Jane Street Group, LLC | 24,950 | $128.0K | 0.00% |
| Simplex Trading, LLC | 17,887 | $85.0K | 0.00% |
| JustInvest LLC | 10,956 | $53.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,803 | $13.0K | 0.00% |
| National Bank of Canada | 1,400 | $7.00K | 0.00% |
| Citigroup Inc | 72 | $0 | 0.00% |
Sold out (8)
Institutions that held Mesoblast Ltd at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Jacob Asset Management of New York LLC | 172,400 | $1.04M |
| Game Plan Financial Advisors, LLC | 21,600 | $130.0K |
| Tobias Financial Advisors, Inc. | 20,000 | $120.0K |
| Brewin Dolphin Ltd | 5,900 | $35.5K |
| Walled Lake Planning & Wealth Management, LLC | 5,719 | $34.0K |
| First Manhattan Co | 200 | $1.00K |
| Barclays PLC | 37 | $0 |
| HM Payson & Co | 50 | $0 |